A PPAR-α ligand was shown to induce apoptosis in breast cancer cells, which may have been due to the inhibition of NF-κB [27], and the activation of PPAR-α also decreased the growth rate of breast cancer cells by reducing the levels of various cell cycle-regulating cyclins [43]. Here, NFKB1 is linked to breast cancer.